Tzivelekis, S., Orange, J., Poulos, C., Meckley, L. M., Peay, H., Sutphin, J., Hernandez-Trujillo, V. P., & Wasserman, R. L. (2023). Development of A Novel Shared Decision Making Aid for Primary Immunodeficiency Diseases. Immunotherapy, 15(9), 647–656. https://doi.org/10.2217/imt-2022-0193

Syed, M. N., Kutac, C., Miller, J. M., Marsh, R., Sullivan, K. E., Cunningham-Rundles, C., Fuleihan, R. L., Kheradmand, F., & Hajjar, J. (2022). Risk Factors of Pneumonia in Primary Antibody Deficiency Patients Receiving Immunoglobulin Therapy: Data from the US Immunodeficiency Network (USIDNET). Journal of Clinical Immunology, 42(7), 1545–1552. https://doi.org/10.1007/s10875-022-01317-2

Lu, H. Y., Sertori, R., Contreras, A. V., Hamer, M., Messing, M., Del Bel, K. L., Lopez-Rangel, E., Chan, E. S., Rehmus, W., Milner, J. D., McNagny, K. M., Lehman, A., Wiest, D. L., & Turvey, S. E. (2021). A Novel Germline Heterozygous BCL11B Variant Causing Severe Atopic Disease and Immune Dysregulation. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.788278

Korenfeld, D., Roussak, K., Dinkel, S., Vogel, T. P., Pollack, H., Levy, J., Leiding, J. W., Milner, J., Cooper, M., & Klechevsky, E. (2021). STAT3 Gain-of-Function Mutations Underlie Deficiency in Human Nonclassical CD16+ Monocytes and CD141+ Dendritic Cells. The Journal of Immunology, 207(10), 2423–2432. https://doi.org/10.4049/jimmunol.2000841

Demirdag, Y., Fuleihan, R., Orange, J. S., & Yu, J. E. (2021). New primary immunodeficiencies 2021 context and future. Current Opinion in Pediatrics, 33(6), 657–675. https://doi.org/10.1097/mop.0000000000001075